- Home
- JILL vs ATAI Comparison
JILL vs ATAI Comparison
Compare JILL & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JILL
- ATAI
- Stock Information
- Founded
- JILL 1959
- ATAI 2018
- Country
- JILL United States
- ATAI Germany
- Employees
- JILL N/A
- ATAI N/A
- Industry
- JILL Clothing/Shoe/Accessory Stores
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- JILL Consumer Discretionary
- ATAI Health Care
- Exchange
- JILL Nasdaq
- ATAI Nasdaq
- Market Cap
- JILL 342.2M
- ATAI 280.2M
- IPO Year
- JILL 2017
- ATAI 2021
- Fundamental
- Price
- JILL $21.52
- ATAI $1.51
- Analyst Decision
- JILL Strong Buy
- ATAI Strong Buy
- Analyst Count
- JILL 6
- ATAI 4
- Target Price
- JILL $38.17
- ATAI $9.00
- AVG Volume (30 Days)
- JILL 83.2K
- ATAI 3.9M
- Earning Date
- JILL 03-19-2025
- ATAI 03-27-2025
- Dividend Yield
- JILL 0.98%
- ATAI N/A
- EPS Growth
- JILL 24.73
- ATAI N/A
- EPS
- JILL 2.82
- ATAI N/A
- Revenue
- JILL $614,918,000.00
- ATAI $331,000.00
- Revenue This Year
- JILL $2.96
- ATAI $80.07
- Revenue Next Year
- JILL $3.03
- ATAI N/A
- P/E Ratio
- JILL $7.64
- ATAI N/A
- Revenue Growth
- JILL 1.57
- ATAI N/A
- 52 Week Low
- JILL $20.81
- ATAI $1.03
- 52 Week High
- JILL $40.61
- ATAI $2.85
- Technical
- Relative Strength Index (RSI)
- JILL 26.08
- ATAI 39.86
- Support Level
- JILL $20.93
- ATAI $1.44
- Resistance Level
- JILL $21.90
- ATAI $1.87
- Average True Range (ATR)
- JILL 1.04
- ATAI 0.19
- MACD
- JILL -0.28
- ATAI -0.07
- Stochastic Oscillator
- JILL 13.69
- ATAI 7.77
About JILL J. Jill Inc.
J.Jill Inc is a national lifestyle brand that provides apparel, footwear, and accessories. The company's products are marketed under the J.Jill brand name and sold through two channels: its e-commerce platform and catalog (Direct) and its retail stores (Retail). Revenue is derived from the sale of apparel and accessory merchandise through the company's Retail and Direct channels, which include website and catalog phone orders. Revenue also includes shipping and handling fees collected from customers.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.